In 2024, Sidra Medicine, a member of Qatar Foundation, showcased its commitment to improving patient care and healthcare access in Qatar and beyond. The hospital achieved significant milestones by providing life-saving care for injured children from Gaza, making advancements in gene therapy, precision medicine, and performing the region’s first high-risk caesarean section in an angiography suite. Chief Executive Officer Dr. Iyabo Tinubu-Karch outlined the accomplishments of 2024 and discussed the strategic goals for Sidra Medicine in 2025, emphasizing the importance of research, innovation, and expanding precision medicine efforts.
One of the main priorities for Sidra Medicine in 2025 is advancing research and innovation, particularly in the field of precision medicine. The hospital is set to launch a clinical trials program focusing on personalised treatments for a range of conditions, with a specific focus on the Arab population. By partnering with major pharmaceutical companies, Sidra Medicine aims to pioneer groundbreaking research in genomics and precision medicine, ensuring that patients receive world-class care without having to travel abroad for medical services.
As part of its commitment to medical tourism, Sidra Medicine aims to position itself as a leading destination for patients within the GCC and MENA regions, further enhancing Qatar’s reputation in advanced healthcare. By offering high-quality healthcare services and a seamless experience for international patients, Sidra Medicine hopes to attract more medical tourists, foster knowledge exchange, and reinforce Qatar’s status as a hub for advanced medical care.
In 2025, Sidra Medicine plans to expand and strengthen its focus on women’s and paediatric care, aiming to become a regional leader in these fields. The hospital is also dedicated to advancing gene therapies for rare genetic disorders, childhood cancers, and inherited diseases, leveraging genetic insights to offer pre-emptive therapies for at-risk children. Additionally, Sidra Medicine is pioneering the use of interventional radiology, a minimally invasive technique that enhances patient care and contributes to the hospital’s reputation as a leader in healthcare.
By aligning closely with Qatar’s national healthcare objectives and Vision 2030, Sidra Medicine plays a crucial role in enhancing healthcare quality and expanding access to advanced medical services for women and children. Key achievements in 2024, such as administering groundbreaking gene therapy for Duchenne Muscular Dystrophy and launching a clinical trials program for the Arab population, demonstrate the hospital’s dedication to research-driven innovation and precision medicine. Through strategic partnerships and cutting-edge treatments, Sidra Medicine continues to pave the way for improved healthcare outcomes in Qatar and beyond.
